FDA ‘Strategic Priorities 2011 – 2015’
Today’s release of a strategic priorities document outlining the goals and strategies that the FDA and its 12,000 employees will pursue through 2015 marks a renewal of our commitment to creating a stronger, more effective agency.
Titled “Strategic Priorities 2011 – 2015: Responding to the Public Health Challenges of the 21st Century,” the 50-page document provides a vision of the FDA that includes:
- a modernized field of regulatory science that draws on innovations in science and technology to help ensure the safety and effectiveness of medical products throughout their life cycles
- an integrated global food safety system focused on prevention and improved nutrition
- expanded efforts to meet the needs of special populations.
Senior staff from the FDA’s seven product and research centers and two major offices contributed to the document. A Federal Register notice that invited public input in October 2010 generated more than 200 comments that were considered for the final document.
The field of regulatory science and innovation is among five cross-cutting areas that will serve as strategic priorities at the agency during the next five years.
The FDA must have the capacity to effectively oversee the translation of breakthrough discoveries in science into innovative, safe, and effective products and life-saving therapies. This document sets forth our priorities for achieving that goal.
Margaret A. Hamburg, M.D.
Commissioner of Food and Drugs